Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data

Not yet recruitingOBSERVATIONAL

Enrollment

1,140

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Xiyanping injection+ antibiotic

DRUG

Antibiotic